Brief: China Regenerative Medicine International Says Substantial Shareholder Ups Stake In Co
24/01/2018 10:17
Jan 24 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* SUBSTANTIAL SHAREHOLDER INCREASED SHAREHOLDING BY 1.55
BILLION
ORDINARY SHARES OF COMPANY
Source text for Eikon: ID:nHKS3ZRxpG
Further company coverage: 8158.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital